Rochester General Health System Suspends Use of Power Morcellator in Gynecologic Surgeries

April 23, 2014

Rochester General Health System is, effective immediately and until further notice, suspending the use of power morcellation in gynecologic surgeries, including hysterectomies.

The Food and Drug Administration (FDA) has issued an advisory stating that the use of power morcellation in some surgeries may spread cancer.
Morcellation is a technique used in minimally invasive/robotic uterine surgery that uses a power tool to cut tissue while still in the body so it can be removed through the smaller incisions.

“Upon review of the FDA communication, RGHS is suspending use of the power morcellator until further notice,” said Eugene Toy MD, Chief, OB-GYN/RGHS. “A formal policy regarding the use of morcellation in gynecologic surgery will be established next month during a special meeting of the GYN OR committee.”

Dr. Toy says that patients scheduled to have surgery with the use of power morcellation will be counseled on this policy change and offered alternative surgical options in the meantime.

Recent News

Vascular_Penfield
Located at 30 Hagen Drive, the newest vascular location offers state-of-the-art technology to its patients.

Wednesday, May 15, 2019

New Vascular Office Opens in Penfield

Located at 30 Hagen Drive, the newest vascular location offers state-of-the-art technology to its patients.

Read News Article
Ticks_Scott_Allan
Immediate Care locations averaging higher numbers than usual.

Wednesday, May 15, 2019

Ticks On The Rise

Immediate Care locations averaging higher numbers than usual.

Read News Article
View All Recent News Articles